Ischemia/reperfusion injury (IRI) is a major cause of acute kidney damage, which often occurs in deceased donor kidney transplants.
Cathelicidin PR-39 peptide possesses anti-inflammatory and
wound repair effects through tissue angiogenesis and anti-apoptosis. This study assessed the role of
PR-39 in anti-apoptosis in vitro using a lentiviral vector with a kidney specific promoter (KSP) to drive
PR-39 expression. Our data revealed that
PR-39 peptide was specifically over-expressed in kidney-derived HK-2 cells, but was scarcely detected in non-kidney tissue-derived cells.
PR-39 over-expression had a protective role in the
hypoxia/re-oxygenation (H/R) treated cells. The anti-apoptotic activity of
PR-39 peptide was mediated by the inhibition of
caspase-2,
caspase-12 and
caspase-3 activity in the endoplasmic reticulum (ER) stress-induced apoptotic pathway. It was also revealed that the anti-apoptotic effect of
PR-39 peptide was mediated by an apoptosis-related
protein, cellular inhibitor apoptosis protein-2 (c-IAP-2). Taken together, the current data demonstrate that
PR-39 expression driven by KSP could prevent kidney damage (apoptosis) from IRI via the ER stress-induced apoptotic pathway.